Brief: Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
22/07/2024 12:27
July 22 (Reuters) - Anebulo Pharmaceuticals Inc
ANEB.O :
* ANEBULO PHARMACEUTICALS AWARDED NIDA GRANT FOR ITS
INVESTIGATIONAL IV TREATMENT FOR ACUTE CANNABIS-INDUCED TOXIC
EFFECTS
Source text for Eikon: ID:nBwVTgppa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results